Stay updated on Depemokimab Clinical Trial in Severe Eosinophilic Asthma
Sign up to get notified when there's something new on the Depemokimab Clinical Trial in Severe Eosinophilic Asthma page.

Latest updates to the Depemokimab Clinical Trial in Severe Eosinophilic Asthma page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.8%
- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.8%
- Check38 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.0%
- Check52 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.0%
- Check59 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in this functionality.SummaryDifference0.1%
- Check81 days agoChange DetectedNew results have been posted, including data from various locations in the U.S., Canada, Europe, and China, detailing the effects of GSK3511294 and placebo on asthma exacerbations and quality of life metrics over 52 weeks.SummaryDifference37%
Stay in the know with updates to Depemokimab Clinical Trial in Severe Eosinophilic Asthma
Enter your email address, and we'll notify you when there's something new on the Depemokimab Clinical Trial in Severe Eosinophilic Asthma page.